SEC Form 4 · accession 0001179110-19-003514
Inotiv, Inc. · NOTVQ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Thomas Oakley
Officer — Chief Operating Officer
Period of report
Mar 6, 2019
Accepted (ET)
Mar 7, 2019 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000720154
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Mar 6, 2019 | P | 10,000 | $1.75 | A | 20,951 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.72 to $1.75, inclusive. The reporting person undertakes to provide to Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.